Kurzübersicht für Glutaminase (GLS) (Middle Region) Peptid (ABIN977471)
Target
Glutaminase (GLS)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-GLS antibody (Catalog #: ARP55098_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
Glutaminase (GLS)
Hintergrund
Sahai (1983) [PubMed 6825316] demonstrated phosphate-activated glutaminase (EC 3.5.1.2) in human platelets. It is the major enzyme yielding glutamate from glutamine. Significance of the enzyme derives from its possible implication in behavior disturbances
Alias Symbols: AAD20, DKFZp686O15119, FLJ10358, GLS1, KIAA0838, GAC, GAM, KGA
Protein Interaction Partner: PARD6A,SNTA1,TAX1BP3,SNTA1